Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Life Science Tools Market Size, Share, and Trends - Global Forecast 2026-2032 | AI, Lab Automation, and Multi-Omics Propel 11.49% CAGR and a USD 389.38 Billion Opportunity

globenewswire.com
TXG Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for 10x Genomics. AGNC Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Agilent. BDX Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Becton Dickinson. BRKR Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Bruker. CNM Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Corning. DHR Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Danaher. HOLX Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Hologic. ILMN Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Illumina. MTX Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Mettler Toledo. PACB Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Pacific Biosciences. RGEN Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Repligen. RVTY Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Revvity. TMO Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Thermo Fisher Scientific. TWST Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Twist Bioscience. WTRG Mentioned as a company in the life science tools market, which is experiencing growth driven by AI, lab automation, and multi-omics. No specific sentiment expressed for Waters Corporation.

Life Science Tools Market Size, Share, and Trends - Global Forecast 2026-2032 | AI, Lab Automation, and Multi-Omics Propel 11.49% CAGR and a USD 389.38 Billion Opportunity Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Life Science Tools Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The Life Science Tools Market research report provides a comprehensive assessment of industry growth, technology adoption, competitive priorities, and regional opportunities. The market is projected to reach USD 201.59 billion in 2026 and expand at a CAGR of 11.49% to USD 389.38 billion by 2032, supported by sustained demand for genomics, proteomics, cell analysis, laboratory automation, analytical instruments, reagents, and sample preparation technologies.

Declining DNA sequencing costs have broadened the use of next-generation sequencing across discovery research, clinical development, public health genomics, and translational medicine. The analysis enables decision-makers to align product development, investment, and market-entry strategies with the technologies and applications demonstrating the strongest momentum.

Market Transformation and Growth Drivers

Life science laboratories are moving from standalone instruments toward connected, automated, and application-specific platforms. Buyers increasingly prioritize solutions that reduce hands-on time, improve reproducibility, support high-throughput and multi-omics workflows, and integrate with laboratory information management systems.

The convergence of research and clinical-grade workflows is also increasing demand for robust documentation and regulatory-ready design under frameworks such as U.S. Food and Drug Administration oversight and the European Union In Vitro Diagnostic Regulation.

Artificial Intelligence and Digital Innovation

Artificial intelligence is reshaping instrument design, assay development, laboratory operations, and data interpretation. Applications include image analysis, spectral deconvolution, protein structure prediction, anomaly detection, digital pathology support, and optimization of sequencing, microscopy, flow cytometry, mass spectrometry, and high-content screening.

Commercial opportunities extend to predictive maintenance, automated quality control, and machine learning-guided assay development. Competitive planning can be strengthened by evaluating these opportunities alongside model transparency, cybersecurity, representative training data, and validation requirements.

Regional Market Insights

Strategic Country and Economic Group Opportunities

G7 markets remain central to high-end instruments, regulated diagnostics, and advanced research platforms. BRICS and ASEAN countries offer volume growth, domestic manufacturing potential, and expanding laboratory capacity, while GCC economies are investing in national biobanks, genomic screening, precision medicine, and healthcare transformation.

Country-level insights covering the United States, Canada, Mexico, Brazil, the United Kingdom, Germany, France, Italy, Spain, Russia, China, India, Japan, South Korea, and Australia support practical prioritization of partnerships, distribution networks, and localized service investments. These comparisons also provide a basis for mitigating regulatory, procurement, technology-access, and supply-chain risks.

Strategic Recommendations

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Life Science Tools Market, by Product Type

7.1. Introduction

7.2. Instruments

7.2.1. Centrifuges

7.2.2. Chromatography Systems

7.2.3. Electrophoresis Equipment

7.2.4. Flow Cytometers

7.2.5. Mass Spectrometers

7.2.6. Microscopes

7.2.7. PCR Machines

7.2.8. Robotics & Automation Systems

7.2.9. Sequencing Instruments

7.2.10. Spectrophotometers

7.3. Reagents & Consumables

7.3.1. Antibodies & Proteins

7.3.2. Cell Culture Reagents

7.3.3. Media, Buffers & Stains

7.3.4. Nucleic Acid Reagents

7.4. Software & Services

7.4.1. Bioinformatics Software

7.4.2. Cloud Platforms

7.4.3. Consulting & Technical Support Services

7.4.4. Data Analysis Tools

7.4.5. Laboratory Information Management Systems

8. Life Science Tools Market, by Technology

8.1. Introduction

8.2. Analytical Chemistry

8.3. Cell Biology

8.4. Genomics

8.5. High-Throughput Screening

8.6. Metabolomics

8.7. Microbiology

8.8. Molecular Biology

8.9. Proteomics

8.10. Synthetic Biology

8.11. Transcriptomics

9. Life Science Tools Market, by Application

9.1. Introduction

9.2. Agricultural Biotechnology

9.3. Basic Research

9.4. Bioprocessing and Biomanufacturing

9.5. Clinical Diagnostics

9.6. Drug Discovery & Development

9.7. Environmental Testing

9.8. Epidemiology and Public Health

9.9. Forensic Science

9.10. Personalized Medicine

10. Life Science Tools Market, by Workflow Stage

10.1. Introduction

10.2. Amplification

10.3. Data Acquisition

10.4. Data Analysis & Interpretation

10.5. Sample Preparation

10.6. Separation & Detection

10.7. Storage & Archiving

11. Life Science Tools Market, by End User

11.1. Introduction

11.2. Pharmaceutical Companies

11.3. Biotechnology Companies

11.4. Academic and Research Institutes

11.5. Contract Research Organizations

12. Life Science Tools Market, by Region

12.1. Introduction

12.2. Asia-Pacific

12.3. Europe

12.4. North America

12.5. Latin America

12.6. Africa

12.7. Middle East

13. Life Science Tools Market, by Group

13.1. Introduction

13.2. NATO

13.3. G7

13.4. BRICS

13.5. European Union

13.6. ASEAN

13.7. GCC

14. Life Science Tools Market, by Country

14.1. Introduction

14.2. China

14.3. United States

14.4. Japan

14.5. India

14.6. Germany

14.7. United Kingdom

14.8. Australia

14.9. France

14.10. South Korea

14.11. Italy

14.12. Canada

14.13. Russia

14.14. Brazil

14.15. Mexico

14.16. Spain

15. Competitive Landscape

15.1. Market Share Analysis, 2025

15.2. Market Concentration Analysis, 2025

15.2.1. Concentration Ratio (CR)

15.2.2. Herfindahl Hirschman Index (HHI)

15.3. Recent Developments & Impact Analysis, 2025

15.4. Product Portfolio Analysis, 2025

15.5. Benchmarking Analysis, 2025

16. Company Profiles

16.1. 10x Genomics

16.2. Agilent Technologies Inc

16.3. Becton Dickinson and Company

16.4. Bio Rad Laboratories Inc

16.5. Bruker Corporation

16.6. Corning Incorporated

16.7. Danaher Corporation

16.8. Eppendorf AG

16.9. F Hoffmann La Roche Ltd

16.10. Hologic Inc

16.11. Illumina Inc

16.12. Merck KGaA

16.13. Mettler Toledo

16.14. Nikon Corporation

16.15. Olympus Corporation

16.16. Oxford Nanopore Technologies plc

16.17. Pacific Biosciences of California Inc

16.18. Qiagen NV

16.19. QuidelOrtho Corporation

16.20. Repligen Corporation

16.21. Revvity Inc

16.22. Sartorius AG

16.23. Sartorius Group

16.24. Shimadzu Corporation

16.25. Standard BioTools Inc

16.26. Tecan Group Ltd

16.27. Thermo Fisher Scientific Inc

16.28. Twist Bioscience

16.29. Waters Corporation

17. Key Experts

List of Figures [21]

List of Tables [364]

For more information about this report visit https://www.researchandmarkets.com/r/6ljkkp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.